IMFINZI was my first foray into the world of pharmaceutical advertising, when I pitched and won the $10M AstraZeneca oncology account. And I had a great realization. For years I’ve had to make RTB’s mean something. Make mountains out of molehills. But for this assignment the benefits were lifechanging, literally. IMFINZI is a stage three lung cancer drug that is revolutionizing treatment and offers a chance at survival for up to three years, where there was once no hope. And as patients live longer, and the trials go on, the survival rate gets longer. So, while there is absolutely no reason not to try this treatment, there are a million reasons why you should.